Vimarsana
Biggest News Aggregation in the World

Cath Stanley News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cath Stanley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cath Stanley Today - Breaking & Trending Today

Huntington's disease sufferer tells of ordeal - Vimarsana News

Huntington's disease sufferer tells of ordeal

Many people with Huntington’s disease are being turned away from traditional mental health support, a charity has claimed as it called for more…

Concern over Huntington's patients 'turned away' from mental health support - Vimarsana News

Concern over Huntington's patients 'turned away' from mental health support

Some mental health services have said that they do not have the specialist provision for patients in need.

Source: aol.co.uk
Mental health needs of Huntington's Disease patients are key - Cath Stanley - Vimarsana News

Mental health needs of Huntington's Disease patients are key - Cath Stanley

Huntington’s disease is a rare condition, it is life-limiting, hereditary, and currently has no cure. You may know someone who has it or you may have heard about it during last year’s Casualty storyline when Ethan Hardy, played by actor George Rainsford, was diagnosed with the disease.

Special Mother's Day remembrance service to be held at Test Valley crematorium - Vimarsana News

Special Mother's Day remembrance service to be held at Test Valley crematorium

Test Valley Crematorium is opening its chapel doors to bring families and friends together to commemorate Mother's Day.

Failure of Genetic Therapies for Huntington's Devastates Community - Vimarsana News

Failure of Genetic Therapies for Huntington's Devastates Community

Scientific American Hopes were high for drugs designed to lower levels of a mutant protein, but development has stalled orange  Advertisement Two pharmaceutical companies have halted clinical trials of gene-targeting therapies for Huntington’s disease (HD), following the drugs’ disappointing performance. Researchers had hoped that the treatments—known as antisense oligonucleotides (ASOs)—would be a game changer for HD, an incurable genetic condition that affects cognition, behaviour and movement. But back-to-back announcements from Roche, headquartered in Basel, Switzerland, and Wave...